Free Trial

Rein Therapeutics (RNTX) SEC Filings & 10K Form

$1.77 +0.02 (+1.14%)
As of 04:00 PM Eastern

Recent Rein Therapeutics SEC Filings

DateFilerForm TypeView
12/06/2024
3:34 PM
Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
3:35 PM
Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Fairey William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
3:38 PM
Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
3:41 PM
Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Aivado Manuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:03 PM
Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
4:17 PM
Aileron Therapeutics, Inc. (Subject)
Rein Therapeutics (Subject)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Filed by)
Form SCHEDULE 13G/A
08/22/2024
3:05 PM
Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Musso Alan A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:06 PM
Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:06 PM
Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Fairey William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:07 PM
Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:09 PM
Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Aivado Manuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
4:12 PM
Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2024
4:23 PM
Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
3:29 PM
Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 424B5
07/26/2024
3:33 PM
Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 424B5
07/26/2024
3:36 PM
Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2024
7:41 AM
Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form ARS
07/09/2024
7:30 AM
Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form DEF 14A
07/09/2024
7:36 AM
Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form DEFA14A
06/17/2024
6:03 PM
Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
5:18 PM
Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:59 PM
Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
5:58 AM
Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
4:19 PM
Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Cunningham Timothy M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/15/2024
4:16 PM
Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
4:54 PM
Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
Form 4/A
05/01/2024
6:15 PM
Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
4:24 PM
Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 424B5
05/01/2024
4:25 PM
Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
4:16 PM
Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/01/2024
7:40 AM
Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
7:54 AM
Aileron Therapeutics, Inc. (Subject)
Rein Therapeutics (Subject)
Form FWP
04/30/2024
2:32 PM
Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/29/2024
7:33 AM
Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 10-K/A
04/16/2024
4:16 PM
Aileron Therapeutics, Inc. (Subject)
Rein Therapeutics (Subject)
Satter Muneer A (Filed by)
Form SC 13D/A
04/15/2024
4:21 PM
Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/15/2024
4:22 PM
Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
3:15 PM
Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Ambros Reinhard J. (Reporting)
Form 4/A
04/10/2024
3:15 PM
Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
VON RICKENBACH JOSEF H (Reporting)
Form 4/A
04/02/2024
5:10 PM
Aileron Therapeutics, Inc. (Issuer)
Rein Therapeutics (Issuer)
Garner Charles (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/01/2024
3:15 PM
Aileron Therapeutics, Inc. (Filer)
Rein Therapeutics (Filer)
Form NT 10-K
AI Boom Takes a Shocking Turn… (Ad)

AI is Creating Fortunes… (but not where you think!) Bryce Paul and the team at Crypto101 just released a brand-new report…

The #1 AI Coin for 2025 (Click here to access it now)
03/29/2024
7:03 AM
AILERON THERAPEUTICS INC (Filer)
Rein Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:RNTX) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners